Cerevance

About:

Cerevance is a biotechnology company that develops novel therapeutics for neurological diseases.

Website: https://www.cerevance.com/

Twitter/X: cerevance

Top Investors: Takeda, Google Ventures, Foresite Capital, Dementia Discovery Fund, Casdin Capital

Description:

Cerevance is a biotechnology company that develops novel therapeutics for neurological diseases, including chronic neurodegenerative conditions such as Alzheimer's disease, Parkinson's disease, frontotemporal dementia, and amyotrophic lateral sclerosis. Using a large and growing repository of over 15,000 human brain tissue samples, the company generates an unprecedented level of expression and epigenetic data, enabling the company to identify the most promising targets for the next generation of treatments for CNS disorders.